HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Peritoneal tuberculosis as a complication in a case of unclassifiable myelodysplastic/myeloproliferative disease].

Abstract
We report the case of a 68-year-old male with a diagnosis of unclassifiable myelodysplatic/myeloproliferative disease (WHO classification), under prolonged steroid treatment and unsuccesful chemotherapy response, who developed progressive asthenia, thoracic pain, minimal efforts dyspnea, and abdominal distension, that initially was suspicious of splenic rupture. Exploratory laparotomy showed multiple peritoneal implants, and a diagnosis of peritoneal tuberculosis was obtained from local biopsy. Definitive diagnosis included a positive result to culture and PCR urine test, together with a possible pleural and splenic tuberculous affectation. Response to tuberculostatic treatment was successful. To the best of our knowledge, this is the first reported case with such characteristics.
AuthorsT Martín Santos, L Morabito, J M Raya Sánchez, M M Alonso Socas, B González González, M T Hernández García, L Hernández Nieto
JournalAnales de medicina interna (Madrid, Spain : 1984) (An Med Interna) Vol. 25 Issue 6 Pg. 287-90 (Jun 2008) ISSN: 0212-7199 [Print] Spain
Vernacular TitleTuberculosis peritoneal como complicación en un caso de síndrome mielodisplásico/mieloproliferativo inclasificable.
PMID19295977 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antitubercular Agents
Topics
  • Aged
  • Antitubercular Agents (therapeutic use)
  • Biopsy
  • Humans
  • Male
  • Myelodysplastic-Myeloproliferative Diseases (classification, complications)
  • Peritoneum (pathology)
  • Peritonitis, Tuberculous (diagnosis, drug therapy, etiology, pathology)
  • Treatment Outcome
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: